tiprankstipranks
Nanobiotix: Innovating Treatments and Transparency
Company Announcements

Nanobiotix: Innovating Treatments and Transparency

Nanobiotix (NBTX) has released an update.

Pick the best stocks and maximize your portfolio:

Nanobiotix, a Paris-based biotech company known for its innovative nanotechnology platforms targeting oncology and CNS disorders, has updated its voting rights and share capital information as of June 30, 2024. The company, listed on both Euronext Paris and Nasdaq, emphasizes its commitment to revolutionizing patient treatment outcomes and has a robust intellectual property portfolio with over 25 patent families. Nanobiotix maintains transparency in its operations by adhering to French Commercial Code regulations, ensuring public access to essential company data regarding voting rights and share capital.

For further insights into NBTX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskNanobiotix to Unveil Future of Nanotherapeutics
TipRanks Auto-Generated NewsdeskNanobiotix Announces Key Share Acquisition Transactions
TipRanks Auto-Generated NewsdeskNanobiotix Executive Acquires Significant Share Volume, Signaling Confidence in Future Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App